United States HR 1499: Protecting Consumer Access to Generic Drugs Act of 2019

Status: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-52, Part I. (as of 2019-05-10)

State: United States · Session: 116 · Bill: HR 1499

Subjects: Administrative law and regulatory procedures, Civil actions and liability, Competition and antitrust, Consumer affairs, Drug safety, medical device, and laboratory regulation, Federal Trade Commission (FTC), Intellectual property, Judicial review and appeals, Licensing and registrations, Prescription drugs

Sponsors: BOBBY L. RUSH, ADAM SMITH, ALCEE L. HASTINGS, ANNA G. ESHOO, Abby Finkenauer, Andre Carson, Angie Craig, BENNIE THOMPSON, Chris Pappas, Chrissy Houlahan, David Scott, Debbie Dingell, Debbie Mucarsel-Powell, Doris O. Matsui, Ed Case, FRANK PALLONE, Gerald E. Connolly, Gilbert Ray Cisneros, Haley M. Stevens, JAMES H. COOPER, JAMES R. LANGEVIN, JANICE D. SCHAKOWSKY, JOHN B. LARSON, Jamie Raskin, Jefferson Van Drew

View United States HR 1499 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.